Risk of herpes zoster with IL-17 inhibitor therapy for psoriasis and other inflammatory conditions
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2019.1597246
Abstract: Abstract Background: Psoriasis is a chronic inflammatory skin disease that has been associated with a significantly higher risk of herpes zoster (HZ). Several newer biologics such as secukinumab, ixekizumab, and brodalumab inhibit IL-17 and have… read more here.
Keywords: inhibitor therapy; herpes zoster; zoster inhibitor; psoriasis ... See more keywords